Cargando…

BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept

Detalles Bibliográficos
Autores principales: Cai, Shaozhe, Hu, Ziwei, Chen, Yu, Chen, Yuxue, Ming, Bingxia, Gao, Rongfen, Li, Zhen, Ye, Cong, Zhong, Jixin, Dong, Lingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313947/
https://www.ncbi.nlm.nih.gov/pubmed/36657954
http://dx.doi.org/10.1136/ard-2022-223529
_version_ 1785067215299543040
author Cai, Shaozhe
Hu, Ziwei
Chen, Yu
Chen, Yuxue
Ming, Bingxia
Gao, Rongfen
Li, Zhen
Ye, Cong
Zhong, Jixin
Dong, Lingli
author_facet Cai, Shaozhe
Hu, Ziwei
Chen, Yu
Chen, Yuxue
Ming, Bingxia
Gao, Rongfen
Li, Zhen
Ye, Cong
Zhong, Jixin
Dong, Lingli
author_sort Cai, Shaozhe
collection PubMed
description
format Online
Article
Text
id pubmed-10313947
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-103139472023-07-02 BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept Cai, Shaozhe Hu, Ziwei Chen, Yu Chen, Yuxue Ming, Bingxia Gao, Rongfen Li, Zhen Ye, Cong Zhong, Jixin Dong, Lingli Ann Rheum Dis Letter BMJ Publishing Group 2023-06 2023-01-19 /pmc/articles/PMC10313947/ /pubmed/36657954 http://dx.doi.org/10.1136/ard-2022-223529 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter
Cai, Shaozhe
Hu, Ziwei
Chen, Yu
Chen, Yuxue
Ming, Bingxia
Gao, Rongfen
Li, Zhen
Ye, Cong
Zhong, Jixin
Dong, Lingli
BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept
title BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept
title_full BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept
title_fullStr BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept
title_full_unstemmed BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept
title_short BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept
title_sort blys/april dual inhibition for igg4-rd: a prospective single-arm clinical trial of telitacicept
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313947/
https://www.ncbi.nlm.nih.gov/pubmed/36657954
http://dx.doi.org/10.1136/ard-2022-223529
work_keys_str_mv AT caishaozhe blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept
AT huziwei blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept
AT chenyu blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept
AT chenyuxue blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept
AT mingbingxia blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept
AT gaorongfen blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept
AT lizhen blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept
AT yecong blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept
AT zhongjixin blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept
AT donglingli blysaprildualinhibitionforigg4rdaprospectivesinglearmclinicaltrialoftelitacicept